UW psilocybin study gives man second chance after 10-year opioid addiction

Published

2025-04-17

min read

Overview

‍

Read Here

‍

From groundbreaking research findings and industry advancements to policy changes and public health initiatives, we cover the stories that matter most.

Subscribe to our newsletter.

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Continue reading

RESEARCH

Kratom Appears Safe in Early FDA Study That Excluded Popular Drinks

New herb-base drinks are widely available in bars and gas stations. Scientists say further research is needed on Kratom's risks.

PRESS RELEASE

SABER Applauds Texas for Advancing Groundbreaking $50 Million Ibogaine Research Bill

The Scientific Association for Botanical Education and Research (SABER) commends the Texas Legislature for passing Senate Bill 2308, a groundbreaking measure that would allocate up to $50 million toward clinical trials investigating ibogaine, a psychedelic compound with emerging potential in the treatment of opioid use disorder, PTSD, and traumatic brain injury.

EVENTS

Fourth International Kratom Symposium

The Fourth International Kratom Symposium is an invitation only event that will bring together the world’s most preeminent scholars on Mitragyna speciosa from across disciplines including botany, chemistry, pharmacology, toxicology, clinical study and population health and health policy.